
Healthcare · BSE
Goldline Pharmaceuticals markets pharmaceutical products under the “Goldline” brand, offering a wide range of medicines across five divisions—Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. These products cater to various medical specialties including physicians, cardiologists, pediatricians, orthopedics, neurologists, critical care experts, and cancer supportive care. Instead of manufacturing medicines directly, the company works with third-party manufacturers who produce products based on its research and specifications while ensuring quality and regulatory compliance. Goldline sells its products through a network of distributors, retailers, and wholesalers, and also supports hospitals and healthcare providers with procurement and supply services. The company currently partners with 15 manufacturers and 7 distributors, with operations spread across states like Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Price Band
₹41 – ₹43
Issue Size
₹270.00 L Cr
Lot Size
3000 shares
GMP
+27.9%
Est. Listing
₹55
at current GMP
Subscribed
840.81x
overall
Open
12 May 2026
Close
14 May 2026
Allotment
15 May 2026
Refund
16 May 2026
Demat Credit
17 May 2026
Listing
19 May 2026